Lynda Mitchell News Today

In this review of April 2024, the editorial team highlighted some of the biggest stories in the pulmonary health space, touching on topics such as air quality issues, asthma, and pneumonia.

The FDA approval of benralizumab for patients ages 6 to 11 with asthma follows the conclusions of the phase 3 TATE study.

Benralizumab was previously approved by the FDA in 2017 as an add-on maintenance therapy for patients 12 years and older.

Additional indication for pediatric patients with severe eosinophilic asthma ...

The approval of benralizumab (Fasenra) is supported by evidence from the phase 3 TATE study.

President Joe Biden and Senator Bernie Sanders continue their push to cut the cost of asthma inhalers and prescription drugs in the US.

Businesses and planning committees are eager for visitors, but some in remote Aroostook County are not sure how they feel about lying smack in the path of totality.

No one knows how many people will travel to Aroostook County for the eclipse on April 8, making planning a bit of a roulette spin.

/PRNewswire/ -- Adults with uncontrolled asthma who take part in virtual asthma coaching show improved asthma control and quality of life, and experience fewer...

/PRNewswire/ -- Allergy & Asthma Network today announced the appointment of Lynda Mitchell, MA, CAE, as its new Chief Executive Officer. The nationwide...